Generic Name: urofollitropin
Applies to urofollitropin: powder for solution
In addition to its needed effects, some unwanted effects may be caused by urofollitropin (the active ingredient contained in Fertinex). In the event that any of these side effects do occur, they may require medical attention.
You should check with your doctor immediately if any of these side effects occur when taking urofollitropin:
Some of the side effects that can occur with urofollitropin may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:
After you stop taking this drug, it is possible that you may still experience side effects that need medical attention. If you notice any of the following side effects check with your doctor immediately:


Applies to urofollitropin: injectable powder for injection, intramuscular powder for injection, subcutaneous powder for injection
The most common adverse events were multi-fetal gestation and birth, abdominal cramps, headache, and ovarian hyperstimulation syndrome (OHSS).[Ref]
Very common (10% or more): Multi-fetal gestation and birth (up to 66.7%), ovarian hyperstimulation syndrome (OHSS) (11.4%) Common (1% to 10%): Hot flashes, vaginal hemorrhage, ovarian disorder (pain, cyst), urinary tract infection, cervix disorder, post retrieval pain, uterine spasms, vaginal spotting, breast tenderness, vaginal discharge, infection fungal, pelvic painFrequency not reported: Abnormal ovarian enlargement Postmarketing reports: Ovarian enlargement, pelvic pain, hot flushes[Ref]
Common (1% to 10%): Hypertension[Ref]
Common (1% to 10%): Acne, exfoliative dermatitis, rash[Ref]
Very common (10% or more): Abdominal cramps (14%), abdominal pain Common (1% to 10%): Nausea, enlarged abdomen, vomiting, diarrhea, constipation, abdominal discomfort[Ref]
Common (1% to 10%): Injection site pain and reactions (redness, bruising, swelling, and/or itching)[Ref]
Common (1% to 10%): Weight gain, dehydration[Ref]
Common (1% to 10%): Neck painPostmarketing reports: Muscle spasm[Ref]
Very common (10% or more): Headache (12.7%)[Ref]
Common (1% to 10%): Pain, fever, accidental injury[Ref]
Common (1% to 10%): Emotional lability, depression[Ref]
Common (1% to 10%): Respiratory disorder, sinusitisPostmarketing reports: Nasopharyngitis[Ref]
Frequency not reported: Allergic, local or generalized skin reactions, delayed-type hypersensitivity[Ref]
1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0
2. "Product Information. Bravelle (urofollitropin)." Ferring Pharmaceuticals Inc, Tarrytown, NY. 
Not all side effects for Fertinex may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

Abdominal or pelvic pain
bloating (mild)


Abdominal or stomach pain (severe)
bloating (moderate to severe)
chest pain or trouble breathing
decreased amount of urine
feeling of indigestion
headache, sudden and severe
nausea, vomiting, or diarrhea (continuing or severe)
pelvic pain (severe)
shortness of breath or wheezing
skin rash or hives
swelling of the arms or lower legs
weight gain (rapid)


Breast tenderness
diarrhea (mild)
headache
hot flashes
nausea
redness, pain, or swelling at the injection site
vomiting


Abdominal or stomach pain (severe)
bloating (moderate to severe)
decreased amount of urine
feeling of indigestion
nausea, vomiting, or diarrhea (continuing or severe)
pelvic pain (severe)
shortness of breath
swelling of the lower legs
weight gain (rapid)

